Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Company News
Events
Directory
Search
Close search
Market Reports
The future of supply chain management in pharmaceuticals
Global regulations and local legislation have made serialisation in the pharmaceutical industry standard practice. And, although serialisation is now commonplace, the supply chain is still beset with potential issues such as counterfeit products, says Andreas Bechthold, General Manager, Mettler-Toledo
Recombinant cultures for superior enzyme output
A non-GMP enzyme manufacturing process at Porton Biopharma has been converted from native production to recombinant using bioinformatics and next-gen sequencing. David Gervais, Head of Product and Fermentation Development, explains the method
Preparing for the paradigm shift in bioprocessing
While upstream titers have improved dramatically over the last decade, downstream processing has remained relatively unchanged. Now is the time to push efficiencies, and Renaud Jacquemart explains how the Natrix technology could offer a helping hand
Advances in biopharmaceutical manufacturing control strategies
The inherent complexity of biopharmaceutical products presents an ongoing challenge for manufacturers, particularly in the drive towards continuous manufacturing operations, writes Dr Richard Moseley, Chief Technologist, Microsaic Systems
Harnessing dark data in early stage drug development
A 1966, anticipating the impact of rapid advances in computing, a <i>Time</i> magazine article hypothesised: “By 2000, the machines will be producing so much that everyone in the US will, in effect, be independently wealthy. How to use leisure time will be a major problem.” Graeme Dennis, Commercial Director of Preclinical Pharma, IDBS, reports
Single-pass tangential flow filtration: A versatile approach to streamlining biomanufacturing
Current trends in the biopharmaceutical industry are driving the implementation of high capacity processes that are capable of reducing costs and equipment footprint without sacrificing manufacturing efficiency and product quality
Review: Cannabis Europa 2019
Scientists, businesspeople and politicians backing the regulation of medical and recreational cannabis have taken the stage of Southbank Centre this week to discuss research and business opportunities
Register now: Lab Innovations celebrates Year of the Periodic Table
Event in Birmingham will feature 35 hours of educational CPD-accredited seminars and the Cleanroom Hub in partnership with <em><a href='http://www.cleanroomtechnology.com'>Cleanroom Technology</a></em> magazine
CMC strategies for the acceleration of commercial-ready ADC manufacturing
The potential for antibody-drug conjugate (ADC) programmes to accelerate from early to late stage clinical development highlights the need to establish commercial launch-ready manufacturing early and efficiently, reports Courtney Morgret, Senior Scientist, Manufacturing Sciences, AbbVie
Video: Silverson manufactures 19ft Duplex Disintegrator mixer in-house
Multimedia showcases the largest batch mixer in the Silverson range as it comes to life
ECH Medical to open the UK's first standalone cannabis clinic
Company has also facilitated the import of the UK's first bulk shipment of cannabis-based medicine
Blockchain: the key to a secure pharmaceutical supply chain
Pharmaceutical companies are increasingly exploring solutions to combat counterfeiters, reports Tom Egan, Vice president, Industry Services, PMMI, Rick Fox, President and CEO, FOX IV Technologies, and Bill McBeath, Chief Research Officer, Chainlink Research
GEA supplies Bracco with falling film evaporator for contrast media
The evaporator Bracco has ordered is specifically designed for use in the production of Iodoftal
Delivering higher value diagnostics
Dr Kevin Robinson had a discussion with Ann Costello, Global Franchise Lead, Centralised Solutions at Roche Diagnostics, following EuroMedLab, regarding how enhancing lab technology, including automated maintenance, is helping to reduce manual operations and the risk of errors
The future of pharmacovigilance and the impact of automation
Pharmacovigilance (PV), the process of identifying, tracking, evaluating and preventing negative outcomes from drug therapies, is a sector that has seen huge growth in recent years. David J. Balderson, Vice President, Global Safety Operations, Sciformix, a Covance company, reports
Butterfly valves: Containment and monitoring for API transfer
Michael Avraam of Chargepoint Technology writes about systems that are critical to preventing HPAPIs harming staff and the bottom line
Establishing a secure supply chain for phyto-APIs
APIs produced from naturally derived materials can be challenging to supply reliably and with consistently high quality. C<sup>2</sup> PHARMA has implemented multiple solutions to ensure supply chain security
Serving up finance
OEMs can help their customers in the pharmaceutical sector to embrace digitalisation with integrated finance, reports Gary Thompson, Sales Director, Siemens Financial Services (UK)
Building a new business model with method lifecycle management
An increased focus on lifecycle management for analytical methods has been seen in recent years from the industry’s regulatory bodies. Method lifecycle management (MLCM) provides an opportunity to continuously improve and ensure quality of data through the application of quality risk management
A natural remedy for brain metastasis
Milk thistle extract might be a promising complementary treatment for cancer patients, reports Andrea Zangara, Scientific Marketing Manager, Euromed
The Manufacturing Chemist outsourcing roundtable: part II
Having talked about upcoming trends, potential growth and in-demand services in Part I, I open the second session by asking the panellists whether they’ll be investing in any particular aspects of their businesses during the next 12 months
A matter of material choice
Dr Kevin Robinson recently caught up with DuPont’s Eric Schmohl, Global Marketing Manager for Tyvek Pharmaceutical Packaging, and Jean-François Teneul, Global Life Sciences Market Leader of Tyvek Protective Apparel, to discuss the importance of protecting both people and product during aseptic fill-&-finish processes
Meeting the global demand for high quality pharmaceutical packaging
Amidst a flurry of recent announcements at the recent DCAT Week in New York, Dr Kevin Robinson sat down with Dr Frank Heinricht, Chairman of the Management Board of SCHOTT AG, to discover how the company is addressing issues in the pharmaceutical value chain, from glass tubing to packaging and the application of artificial intelligence
Continuous manufacturing: making it real
Industry pioneers GEA, Siemens and Perceptive Engineering recently hosted the inaugural Reality of Continuous Pharmaceutical Manufacturing conference in Durham, UK, to examine the current status of going conti and present real-life applications to an international audience. Dr Kevin Robinson reports
Previous
1
2
3
4
5
6
(current)
7
8
9
Next
Trending Articles
Drug dose delivery development, manufacturing and commercialisation trends: part II
In the wake of patient-centricity in the pharmaceutical industry, drug delivery technologies have emerged as a central driver of therapeutic and patient success. Dr Kevin Robinson went online with Manuel Leal, Business Development Director, Idifarma, Steve Rode, Manager Business Development, Capsules and Health Ingredients, Lonza, and John Ross, President, Mayne Pharma US/Metrics Contract Services, to find out more
How to avoid sticking and picking in the tableting industry
John Norman and Kevin Queensen of Natoli Engineering explain
Adding more to the cell and gene therapy playbook
With notable advances in various forms of administration, including making the use of viral vectors safer, non-viral delivery with lipid nanoparticles and the growing application of electroporation, Dr Kevin Robinson (KSR) recently caught up with Jason Potter (JP), Director of Cell Biology R&D at Thermo Fisher Scientific, to learn more about how the company is helping the pharmaceutical industry to develop cell and gene therapies
How to proactively address EU HTAR implementation challenges before 2025
Data landscape challenges within the European Union (EU) have historically been driven by the different laws, processes and regulatory standards of its 27 member states (MS). As a result, drug therapeutics and health technology developers have faced the challenge of duplication of assessment efforts
Highly potent formulation development in oncology
Formulation development is a dynamic and experimental process. However, certain challenges are presented to CDMOs that add a layer of unnecessary pressure to the development process — some of which are avoidable. Louise Carpenter from PCI Pharma Services discusses
Upcoming event
BIO International Convention Digital
3-6 June, 2024 | Convention | San Diego, US
See all